Dendreon Corp, located in Dix Hills, NY, is a pioneering leader in cellular technology, revolutionizing medicine through innovative science and cellular therapies. With a singular focus on improving the lives of patients, Dendreon enables the future of complex cell therapies through research, development, and strategic partnerships.
The company's flagship innovation, Provenge (sipuleucel-T), was the first FDA-approved cellular immunotherapy on the market, benefiting nearly 40,000 men. Dendreon also offers expertise in cellular therapy manufacturing, assisting companies in bringing life-saving innovations from clinical research to production, shaping the future of medicine through cutting-edge cellular therapies.
Generated from the website